Addressing the Challenges of Low Clearance in Drug Research

Journal Title: The AAPS Journal - Year 2015, Vol 17, Issue 2

Abstract

As a result of high-throughput ADME screening, early metabolite identification, and exploration of novel chemical entities, low-intrinsic-clearance compounds continue to increase in drug discovery portfolios. Currently available in vitro tools have limited resolution below a certain intrinsic clearance value, which can lead to overestimation of clearance and dose and underestimation of half-life. Significant advances have been made in recent years and novel approaches have been developed to address the challenges of low clearance in drug discovery, such as the hepatocyte relay method, use of qNMR-based standards of biosynthesized drug metabolites to permit monitoring metabolite formation, coculture hepatocyte systems, and the time depending modeling approach. Future development in the field will enable faster, more precise, and lower cost profiling of the properties of low-clearance compounds for intrinsic clearance, metabolite identification, and reaction phenotyping.

Authors and Affiliations

Li Di, R. Scott Obach

Keywords

Related Articles

Novel Nanostructured Solid Materials for Modulating Oral Drug Delivery from Solid-State Lipid-Based Drug Delivery Systems

Lipid-based drug delivery systems (LBDDS) have gained significant attention in recent times, owing to their ability to overcome the challenges limiting the oral delivery of poorly water-soluble drugs. Despite the success...

Glial–Neuronal Interactions—Implications for Plasticity and Drug Addiction

Among neuroscientists, astrocytes have for long played Cinderella to their neuron stepsisters. While the importance of glia in regulating brain activity was predicted by Ramon y Cajal more than a century ago (Garcia-Mari...

Searching for polymorphisms that affect gene expression and mRNA processing: Example ABCB1 (MDR1)

Cis-acting genetic variations can affect the amount and structure of mRNA/protein. Genomic surveys indicate that polymorphisms affecting transcription and mRNA processing, including splicing and turnover, may account for...

Erratum to: Modeling the Effects of Vaccination and Treatment on Pandemic Influenza

The online version of the original article can be found at 10.1208/s12248-011-9284-7.

First Characterization of AKB-48 Metabolism, a Novel Synthetic Cannabinoid, Using Human Hepatocytes and High-Resolution Mass Spectrometry

Since the federal authorities scheduled the first synthetic cannabinoids, JWH-018 and JWH-073, new synthetic cannabinoids were robustly marketed. N-(1-Adamantyl)-1-pentylindazole-3-carboxamide (AKB-48), also known as API...

Download PDF file
  • EP ID EP680921
  • DOI  10.1208/s12248-014-9691-7
  • Views 284
  • Downloads 0

How To Cite

Li Di, R. Scott Obach (2015). Addressing the Challenges of Low Clearance in Drug Research. The AAPS Journal, 17(2), -. https://europub.co.uk/articles/-A-680921